MSFT vs STRO
Microsoft Corporation (MSFT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. Revenue was up 17.8% from 2025-06-30 to 2026-06-30. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MSFT currently screens at market cap $3.71T and trailing P/E 38.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MSFT and STRO stock pages for the full models.
Not investment advice.